Chipotle pulled jalapeños from its restaurants Tuesday after 110 people contracted Salmonella in Minnesota — and once again, the chain that's been sickening customers for a decade offered boilerplate while the FDA offered silence.

This is the same company implicated in at least five separate foodborne illness outbreaks between 2015 and 2018, including E. coli that sickened 60 people across multiple states and a Salmonella outbreak in Minnesota traced to tomatoes at a single location. Each time, Chipotle promised reform. Each time, the FDA conducted its traceback, issued its findings, and nobody in a suit faced consequences. Now the cycle repeats.

According to the Wall Street Journal, first reported by Fox Business, the Minnesota Department of Health identified 110 cases of Salmonella Javiana. Of the 84 people interviewed after falling ill, 89% reported eating at Chipotle between mid-June and last month. Carlota Medus, senior epidemiologist supervisor in the department's foodborne diseases unit, provided the data. The FDA says it is "conducting a traceback investigation involving jalapeños and other potential sources." That's the same language the agency deploys every time — investigate, trace, move on.

Chipotle's response was straight from crisis-management template. "The health and safety of our guests and employees is our highest priority," the company said. Chief corporate affairs and food safety officer Laurie Schalow told CNBC: "We have a robust ingredient traceability system and, upon learning of a potential Salmonella outbreak in the supply chain impacting several food service retailers, we proactively identified jalapeños as a potential common ingredient from a common lot, removed them from the restaurants where they had been distributed, and replaced them with product from different growers."

Robust traceability — after 110 people are already sick. The system traced the problem only after bodies started hitting the epidemiologist's desk.

Investors noticed the pattern. Chipotle shares closed nearly 10% lower, according to CNBC. The Guardian reported a 7% drop in afternoon trading. The sell-off signals that Wall Street, at least, remembers 2015. The public should too.

This outbreak is also running parallel to a separate and far larger crisis. The cyclosporiasis outbreak — an intestinal illness — has sickened more than 6,700 people across nine states and killed two in Michigan, according to The Guardian. The FDA linked that outbreak to iceberg lettuce sourced from Taylor Farms operations in central Mexico. Chipotle says it doesn't serve ingredients tied to the cyclosporiasis outbreak but admitted concerns about foodborne illness already hurt sales in late July.

So two outbreaks, two supply chain failures, two American food suppliers linked to illness — and the same agency, the FDA, doing what it always does: tracing after the fact, issuing no warnings before the damage, holding no one accountable at the top. The Guardian and CNBC both noted the FDA's ongoing traceback. Neither pressed on what the agency knew, when it knew it, or whether any grower or distributor will face real penalties.

Chipotle will replace its jalapeños. The stock will recover. The FDA will close its file. And the next time a common lot of contaminated produce reaches hundreds of restaurant locations across the country, the same system will catch it the same way — after you're already sick.